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The main objective of this research was to uncover the potential of Near Field Communication (NFC) 
technology solutions for Health and Medical marketing, primarily from the perspective of the business-
es. More specifically, to assess the possible benefits, challenges and ultimately the conceivability of 
utilizing NFC Technology solutions in Over-the-Counter (OTC) Pharmaceuticals, in Finland. 
 
The framework of the research consists of two main chapters. The initial chapter, the Literature re-
view includes several key aspects. Firstly, explanation over NFC technology, its usage modes, future 
predictions and safety or security concerns. Secondly, an overview of Finnish OTC Pharmaceutical 
Markets and marketing, along with relevant findings concerning Health and Marketing, specifically the 
possibilities of NFC technology in Health and Medical marketing. Thirdly, relevant theories and findings 
concerning consumers’ decision making, adoption processes and technology acceptance. The second 
chapter consists of the explanation and illustration over the novel NFC concept solution, the PIS – a 
personal mobile drug checker, used as the practical example throughout this research. As well as find-
ings over the possible future of OTC Pharmaceutical Markets in Finland. 
 
The primary research method in this thesis was qualitative. The study was conducted through semi-
structured personal interviews, with professionals from the Pharmaceutical and Medical industry, in 
order to find answers to the research questions. 
The research findings indicated that there are several benefits that could arise from the utilization of 
such NFC solutions, as the PIS, in OTC Pharmaceuticals. Most apparent were the possibilities for im-
proved point-of-sale communications and services, post sales support, and the ability for the busi-
nesses to positively differentiate their products and services i.e. competitive advantage. However, 
several challenges were also noted, most apparent challenges were concerned with the current infra-
structure i.e. the current level of devices and services.  
 
Ultimately, the validity of the assessed research questions was established, with findings that indicated 
the distinct conceivability and plausibility of such solutions. The results can hence be used to further 
research and determine actual practicalities and determinants involved in the implementation of such 
systems. For this purpose, future research should focus on aspects concerning consumers’ acceptance 
and willingness towards adopting and using the technology. 
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1 INTRODUCTION 
 
The recent developments and advancements, in regards to upcoming technologies has 
altered the landscape of the current markets and transformed the methods and means 
of how the businesses’ and marketers of today operate. Especially the development of 
mobile applications and solutions has been immense. These current and upcoming 
solutions offer new ways for enhanced communication and service exchange. The ena-
bled opportunities and overall impact on both the businesses and consumers’ is con-
siderable enough to further investigate the implementation and application possibilities 
of such promising technology solutions. 
Amongst these emerging technologies is Near Field Communication or NFC technology 
(explained in section 2.1). NFC technology possesses vast potential, in terms of trans-
forming existing communication methods, as well as altering existing product and ser-
vice offerings. The impact of technology on communication is imminent, the rise of 
mobile and location based communication services constitutes as the next step towards 
more individual and relevant means of service and information exchange. Modern 
technology, such as NFC, allows the businesses to even further cater to the needs of 
the consumers. With vast possibilities for more enhanced applications, products and 
services. The increase of NFC technology is also noted in recent forecasts, which pre-
dict that the amount of NFC equipped devices will reach approximately 700 million 
units, by the end of 2016 (Berg Insights 2012). 
 
Due to the unique capabilities that NFC technology possesses, the window of oppor-
tunity for creating more value is within reach of the decision makers and the key play-
ers of the respective industries. At the forefront of these industries or markets, one 
may consider to be the Health and Medical markets. Especially whilst considering the 
opportunities that present themselves when bringing together NFC technology and 
Pharmaceutical products and services.  
This research will be evaluating and examining the conceivability of the aforemen-
tioned scenario in Over-the-Counter (OTC) Pharmaceuticals i.e. prescription-free or self 
care medicinal products, within the Finnish markets.  
Especially OTC Pharmaceutical markets can be considered as becoming increasingly 
more interesting and lucrative for the actors within the Pharmaceutical industry, due to 
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the steadily inclining price and sales margins of said products (Pharma Industry Finland 
2012). And therefore, this research also sets out to examine the possible readiness, 
willingness and need from the consumers’ side, regarding the introduction of NFC 
technology solutions to the examined markets. In order to ultimately assess the con-
ceivability of said scenario, from the perspective of the businesses’.  
 
For this sake, a specific NFC concept solution was chosen, to act as an example of the 
capability of NFC technology, in regards to Health and Medical products and services. 
In this research, the example solution utilized is the Pharmaceutical Information Sys-
tem (explained in chapter 3) proposed by Jara et al., an NFC technology based person-
al drug checker, designed for the purposes of solving issues concerning adverse drug 
reactions (ADRs), drug compatibility and allergy detection.  
Especially in the case of ADRs, the possible beneficial economic impact alone, resulting 
from the utilization of such solutions could prove to be rather noticeable. When consid-
ering the fact that according to the European Union, the estimated total cost to society 
resulting from ADRs in the EU is € 79 billion. (European Union 2008)  
 
Henceforth the research is divided into five main chapters. The initial two chapters will 
establish the framework for this research. The methodology chapter will present the 
main research questions and objectives, as well as the qualitative research methods 
and approaches used in the study. The findings and discussion chapter will present the 
main findings of the research. The final chapter will conclude the research findings, 
along with the research limitations and premises for future research. 
 
 
2 LITERATURE REVIEW 
 
The following sections of the literature review will cover relevant aspects of NFC Tech-
nology, OTC Pharmaceutical Markets and Marketing, Marketing and Health, and Con-
sumer Behaviour.  
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2.1 Near Field Communication (NFC) 
 
 
Near Field Communication or NFC technology was initially launched in 2004, by the 
joint co-operation between Nokia, Sony and Philips, with the establishment of the NFC 
Forum (VTT 2007: 9-18). The core goal of the NFC Forum is geared towards advanc-
ing, enforcing and educating usage and implementation of NFC short-range wireless 
interaction technologies (NFC Forum 2011a). 
 
NFC can be described as a short range (0-4 cm.), wireless or point-to-point intercon-
nection technology, that has evolved from earlier forms of Radio Frequency Identifica-
tion (RFID) contactless identification and interconnection technologies.  
NFC is based upon on the more widely used and already available RFID standards, 
thus allowing NFC device compatibility with existing RFID based systems and infra-
structure (VTT 2007: 9-18; NFC Forum 2011b).  
 
RFID technology is based upon electromagnetic wireless communication, commonly 
conducted with and between a reader device and passive tags. The tags receive power 
supply through the electromagnetic field of the reader device, thus the tags are con-
sidered as not having independent power supply (Roberts 2006). An NFC reader ena-
bled mobile device, is a device which has an RFID reader built into it, for example NFC 
enabled smartphones. In this system scenario, the built in NFC/RFID reader in the de-
vice, both powers and reads the NFC/RFID tags. As well as passing along information 
from the tag to the device (Isomursu et al. 2008; Hardy & Rukzio 2008; Sanchez et al. 
2008). And in comparison to RFID, NFC technology also offers the possibility for differ-
ent operation modes, explained in detail in section 2.1.1.  
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NFC enables users of for example mobile or handheld electronic devices to access con-
tent and services in an intuitive way (Figure 1.), via bringing the devices into close 
proximity or contact with other devices or smart objects (e.g. sensors, tags or devices). 
In other words, enabling connection between NFC enabled devices and/or objects by 
either touching or bringing these into a close proximity of each other (VTT 2007: 9-
18). 
 
Due to its variability and advanced usage possibilities, the inclusion of NFC technology 
in especially mobile devices is rapidly increasing (NFC World 2012a; Ok et al. 2010: 
336 - 337).  As an example of this change in supply and demand, many of the most 
known device manufacturers or brands have opted for NFC technology as well, includ-
ing the likes of BlackBerry, HTC, LG, Nokia, Samsung, Sony and many more rumored 
to follow. (NFC World 2012b; NFC Forum 2012b) 
 
Figure 1.  NFC enabled Phone and Tag wireless interaction. (Forum Nokia 2011) 
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NFC based connection technology is considered to possess a large potential for con-
sumers and businesses alike, in terms of usage, interoperability and implementation 
possibilities for various different purposes and application methods. Including current 
and future usage possibilities in consumer electronics, access control, healthcare, in-
formation collection and exchange, loyalty and promotion services, different forms of 
marketing and advertising, various forms of secure payment and transfer methods, as 
well as public and commercial transport (Ok et al. 2010: 336 – 337; NFC Forum 
2012b). 
 
The growth of NFC is also noted in recent estimates, which also portray both, the 
growing demand and sales of especially smart-phones, as well as the inclusion of NFC 
technology in said devices. According to Berg Insights (2012) ; 
 
“Global handset shipments grew 15 percent in 2011 to about 1.5 billion  
 units, although the growth rate slowed down in Q4-2011 in the wake  
 of the deteriorating macroeconomic conditions, especially in Europe.  
 Global sales of feature phones were nearly flat, while smartphone  
 shipments grew almost 60 percent to 470 million units in 2011.”  
(Berg Insights 2012) 
  
 
According to these recent estimates, the amount of NFC technology enabled mobile 
devices is growing and will continue to grow even further. Berg Insights estimates that 
NFC enabled device sales reached up to 30 million units in 2011, in comparison to sales 
of 3 million units in 2010 (Berg Insights 2012a). Comparing these estimates to the re-
sults presented by IMS research, that stated the number of units sold in 2011, being 
closer to 35 million units and the forecasted sales for 2012 are estimated to reach up 
to 80 million units (IMS Research 2011).  
 
Furthermore, according to Berg Insights, the estimated amount for NFC equipped de-
vices will continue to grow and reach approximately 700 million units, by the end of 
2016. As illustrated in Figure 2 (Berg Insights 2012a; Berg Insights 2012b). 
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2.1.1 Device Modes and Usage 
 
NFC enabled devices allow the users to both control the operating modes, as well as to 
opt between the three different device operating modes (VTT 2007: 9-18; Finkenzeller 
2006). NFC devices are able to change their operation modes to be in either in a Read-
er/Writer mode, Peer-to-Peer mode or Card emulation mode (NFC Forum 2011b). The 
three operating modes and their functions can be explained as follows (NFC Forum 
2011b); 
  
Reader/Writer mode: where a user touches an NFC-enabled device against an NFC 
tag. The data stored in the tag is then read by the device, resulting in the provision of 
information to the device. Reader/Writer mode enabled applications posses’ great po-
tential in use cases of for example obtaining information about a product in store, or 
for the provision of information about products, via touching an NFC enabled reading 
device to the tags located on the packages. (Ok et al. 2010: 336; NFC Forum 2011b). 
 
Figure 2.  Projected attach rate for handset connectivity technologies, World 2010-
2016. (Berg Insights 2012a) 
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Peer-to-Peer mode: where NFC is used to enable communication between two NFC 
enabled devices, in order for data to be transmitted or exchanged locally between the 
two devices. (VTT 2007: 9-18; NFC Forum 2011b) 
 
Card Emulation mode: where the NFC device appears to an external reader in a 
similar fashion than that of a traditional contactless smart card. This enables for exam-
ple contactless payments and ticketing. (VTT 2007: 9-18; NFC Forum 2011b) 
 
Also, in the Reader/Writer operating modus, NFC devices are compliant with both the 
ISO14443A and ISO14443B standards, which enable interoperability with objects or 
devices that are also used for RFID enabled technologies. Therefore, as mentioned 
previously, an NFC enabled device is also capable of operating and functioning with 
RFID based systems (VTT 2007: 9-18; NFC Forum 2011b). Some benefits and future 
scenarios, involving the device modes and their application possibilities are also illus-
trated in Figure 3. (Ok et al. 2010: 337) 
 
 
 
As discussed previously, NFC enabled mobile devices, especially smart-phones, are 
already in wide usage. These devices are used for a variety of different purposes, by 
several different industry sectors. For example, NFC technology can be found in various 
smart posters or other out-of-home advertising and information retrieval systems, such 
as “Touch and Access” solutions (Isomursu et al, 2008 :17-24), as well as in wireless 
payment applications such as the “Google Wallet” NFC based payment system (Google 
2012).  
Figure 3.  Benefits and future scenarios of NFC device modes. (Ok et al. 2010) 
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NFC is considered as one of the novel solutions amongst emerging technologies, most-
ly due it’s variability in functions and vast number of implementation possibilities.  
As well as due to the close range or touch interaction and intercommunication capabil-
ity of NFC technology, which enables the users to interact and perform functions with 
minimal physical effort (Chavira et al 2008: 666-669; O’Neil et al 2007: 19-36). 
 
In accordance with the previously mentioned application possibilities, this research 
paper will be mainly exploring the possibilities of Reader/Writer mode devices and their 
interaction possibilities between NFC objects or devices. Due to the fact that the ex-
ample system solution examined in the latter part of the research, mainly deals with 
NFC technology enabled mobile device interaction applications and usage possibilities 
with said operating mode (Jara et al., 2010).  
 
2.1.2 Privacy and Security 
 
Issues concerning the safety and security of various NFC technology related applica-
tions may be considered as paramount, and as being one of the main initial obstacles 
for consumer acceptance and adaptation of novel NFC enabled services and products 
(Abd Allah, 2011: 51-56).  
 
Despite the fact that NFC technology is limited to a functioning communication range 
of only a few centimeters distance, there are several privacy and security threats that 
may be imposed on to the devices or the passive elements i.e. tags. In the case of 
viewing the possible threats imposed on to the Reader/Writer mode devices, as they 
are most relevant to this research, one of the main harms that can be opposed on the 
devices is via the NFC tags. These can be configured to a read-only state, thusly there 
can be several security issues that can arise from for example malicious acts performed 
on the tags. These include attacks on the Tags via replacing existing tags with mali-
cious or tampered tags and Inserting malicious or tampered tags on top of the original 
tags (Abd Allah 2011: 51-56; Finkenzeller 2006). 
 
Also, in most cases NFC enabled mobile devices today are technically highly advanced 
and able to perform and function beyond the realms of NFC or RFID related technolo-
gy, as is the case with for example newer smart-phones or PDAs. Therefore the risk of 
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Figure 4.  Possible threat scenarios and attacks involving NFC technology. Model 
adapted from Finkenzeller (2006). 
potential harm and malicious attacks on these devices can be considered as high, due 
to both the activities performed with these devices, as well as the amount of possible 
sensitive data these can be used to transfer and exchange i.e. personal information , 
passwords etc. These attacks may be performed with or without the knowledge of the 
user i.e. user initiated attack or attack by hackers (Abd Allah 2011: 51-56; Finkenzeller 
2006). 
 
Figure 4 provides an overview of the previously mentioned possible attacks on the 
Reader/Writer enable environment. Noteworthy is the fact that the other communica-
tion modes are in most cases in a similar situation, in regards to vulnerability. Especial-
ly with attacks over the Air Interface. These can largely be considered as similar and 
the NFC devices involved in the attacks can be tampered with, via either the user 
themselves or by the acts of an outsider i.e. hacker (Abd Allah 2011: 51-56; 
Finkenzeller 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The issues involving privacy and security can be considered as paramount, in regards 
to the possible success and widespread adaptation of novel NFC technology solutions.  
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Especially when dealing with user sensitive data transfers via NFC devices. Although 
NFC based systems are considered as safe and secure, the possible problems, attacks, 
technical malfunctions or difficulties that the technologies are exposed to, and that 
may occur or be inflicted upon the systems, could have severe consequences (VTT 
2007 :18-19). Also notable is the fact that NFC technology based secure functions, 
such as NFC based wireless payment systems are inherently more secure than tradi-
tional methods of payment, such as credit cards. Due to the fact that the ISO 14443 
operating based standards used in NFC technologies, allows the account information to 
be encrypted, simultaneously allowing different encryption possibilities performed by 
the users themselves. Also, the very short range of device communication functionality 
provides can in some cases provide sufficient enough of an obstacle in order to avoid 
for example tampering or unauthorized access of data or information. However, since 
NFC is a wireless interconnection technology, the possibility for attacks performed on 
devices and passive components remains an important factor and a key point of con-
sideration, for both the providers and consumers (VTT 2007: 18-19). 
 
The regulations in Europe concerning security issues around NFC or RFID technology 
are enforced by the European Union (EU). All issues regarding security and privacy 
with NFC or RFID technology are based upon the laws and legislations of the EU, were 
both NFC and RFID related privacy and security are covered by the General Data pro-
tection plan. Which is based upon the “Directive 95/46/EC of the European Parliament 
and of the Council of 24 October 1995 on the protection of individuals with regard to 
the processing of personal data and on the free movement of such data “ (European 
Commission 2007).  
 
Section 2.2 will provide information and findings concerning Over-the-Counter (OTC) 
Pharmaceutical markets, as well as regulations concerning OTC Pharmaceutical mar-
keting in Finland. Along with findings over current trends and future possibilities con-
cerning Health and Medical mobile services and applications. Examining these trends 
and current state is particularly relevant, when considering the possible conceivability 
of utilizing applications and services, such as the PIS solution in Health and Medical 
Marketing.  
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2.2 Over-the-Counter (OTC) Pharmaceutical Markets and 
Marketing in Finland 
 
 
 
Over-the-Counter or OTC Pharmaceuticals is a term describing medicinal products that 
can be purchased without a physicians prescription, i.e. prescription-free or self care 
medicinal products, products that are typically extensively researched and considered 
to be safe basic medicines. Thusly these products are typically accompanied by a long 
history of market availability and more knowledge and research over possible adverse 
side effects and adverse interactions between other substances. (Pharma Industry Fin-
land 2010a) 
 
 
2.2.1 OTC Pharmaceutical Markets in Finland  
 
In Finland, the pharmacies are responsible for the distribution of OTC pharmaceuticals 
to end consumers, with the exception of nicotine replacement products, that are al-
lowed to be sold in regular convenience stores (Pharma Industry Finland 2010b; 
Pharma Industry Finland 2010c). The categorization into prescription and prescription-
free medicines is decided upon by The Finnish Medicines Agency (Fimea) and the Eu-
ropean Medicines Agency (EMA). Also, notable is the fact that certain OTC pharmaceu-
ticals can be considered as nearly equally effective as their substance related prescrip-
tion pharmaceutical versions, containing nearly the same active ingredients, with the 
difference being that OTC pharmaceuticals are not allowed to contain similar amounts 
of the actual active ingredients, as the prescription pharmaceuticals (Pharma Industry 
Finland 2012a ; Fimea 2010a). 
 
According to the Association of Finnish Pharmacies, in the beginning of the year 2011, 
Finland had a total of over 800 active pharmacies, which supplied medicinal products 
to the majority of all Finnish municipalities. As of current, a few dozen of these phar-
macies are active online as well, selling the OTC pharmaceutical products through the 
internet, directly to end the consumers. (The Association of Finnish Pharmacies 2012).  
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Figure 5.  The trend in wholesales to pharmacies, hospitals and retail stores in 
Finland, 2002 - 2011. (Pharma Industry Finland, 2012b) 
e). 
The Finnish pharmaceutical markets are commonly divided according to the distribution 
channels, where sales through pharmacies account for approximately 75% and sales 
through hospitals for approximately 23%, of the total markets. The remaining percent-
ages are accounted with the sales of nicotine replacement products, through conven-
ience stores, with roughly 2% of the whole. And with 1% of the medicinal products 
being sold through special permits, handed out by Fimea, in most cases these are 
medicines that are otherwise not available in Finland. (Pharma Industry Finland 2010d)  
 
According to the Finnish Pharmaceutical Data Ltd, the sales of medicines in 2011 
reached a total of 2005 Million Euros (€), with wholesale prices. OTC pharmaceutical 
sales accounted for 230 Million € of the total sum, as illustrated in Figure 5. (Pharma 
Industry Finland 2012b)  
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Figure 6.  The wholesale price index for medicines in Finland, 2000 - 2011. 
(Pharma Industry Finland 2012c). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
However, notable is the fact that the price on medicines in Finland has steadily de-
clined during the last decade, with the wholesale index for prescription medication 
showing a decrease of over 20 %, between 2000 - 2011.  
With the exception of self care medicines i.e. OTC medicines. The price of OTC medici-
nal products has continuously inclined throughout the last ten years, as shown in Fig-
ure 6. (Pharma Industry Finland 2012c)  
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2.2.2 OTC Pharmaceutical Marketing in Finland. 
 
 
The core purpose of OTC Pharmaceutical marketing, as described in the Pharma Indus-
try Finland’s Code of Ethics (2008) ; 
 
 
“Correct information on pharmaceuticals promotes their correct use. The market-
ing of non-prescription medicines to consumers provides them with information 
about the available treatment options in cases where the treatment of the illness 
does not call for medical attention, directing the consumers towards the correct 
and safe use of medicines.” (Pharma Industry Finland 2008: 3) 
 
 
As stated in the previous section, for the regulatory side of Pharmaceutical marketing, 
the main governing agency in charge is Fimea, which is in charge of the overall super-
vision and monitoring of the pharmaceutical industry in Finland. These set regulations 
and guidelines are as well complimented and stated within the Pharma Industry Fin-
land‘s Code of Ethics (Pharma Industry Finland 2008). Fimea is the main central ad-
ministrative agency that operates in behalf of the Ministry of Social Affairs and Health 
in Finland. And the core aim of Fimea is to ensure and enforce secure and safe usage 
of medicinal products and also to aid in the development of the Finnish pharmaceutical 
sector (Fimea 2010a ; Pharma Industry Finland, 2008).  
 
Fimea also works in collaboration with EMA, in order to be in accordance with both 
Finnish and European laws, regarding medicinal products. This means that all products 
have to first gain authorization and approval from Fimea, prior to making the products 
available to the public or any institution that distributes medicinal products. 
Thus only the medicinal products that comply with the set requirements and that have 
been found to be in accordance with the medicinal regulations, in terms of being suffi-
cient in both quality and safety of use, are allowed to be introduced to the markets 
(Finlex, 10.4.1987/395). 
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There are however differences in the legislations or laws, concerning the marketing 
and advertising of pharmaceuticals. These laws prohibit the direct marketing and ad-
vertising of prescription medicinal products to end consumers. Prescription medicines 
are only allowed to be marketed to medical practitioners and pharmacists.  
Only prescription-free or OTC pharmaceuticals are allowed by law to marketed directly 
to the end consumers (Pharma Industry Finland 2008).  
 
Nevertheless, there are some basic rules and regulations concerning pharmaceutical 
marketing, that are applicable regardless of the medicinal products being prescription 
or prescription-free. These regulations are enforced by Fimea and stated in the PIF 
code of ethics (Pharma Industry Finland 2008). Both of which state that prior to any 
marketing endeavors are granted permission to launch, the medicinal products must 
first gain authorization and be granted a license (Finlex, 10.4.1987/395).  Furthermore, 
the marketing and advertising of medicinal products is not allowed to be misleading in 
any way or form and all marketing communications must comply with the information 
of the product in question (Finlex, 10.4.1987/395).  
 
Regulations concerning the actual marketing communications of medicinal products 
state that, all messages are obliged to contain all the necessary information, regarding 
correct usage of the products, as well as encouragement towards abiding by the in-
structions provided with the products in question. Furthermore, all marketing and ad-
vertising communications have to conway a clear and concise message, in terms of 
clarifying the consumers over the fact that the advertised product is in fact a medicinal 
product, despite being available for purchase without a prescription. (Pharma Industry 
Finland 2008) 
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2.2.3 Marketing, Health, Pharmaceuticals and NFC 
 
 
 
According to the American Marketing Association (AMA), “Marketing is the activity, set 
of institutions, and processes for creating, communicating, delivering, and exchanging 
offerings that have value for customers, clients, partners, and society at large.” (Amer-
ican Marketing Association 2007) 
 
And when defining Health Marketing, the Centers for Disease Control and Prevention 
(CDC) have adapted the marketing definition provided by the AMA, and defined Health 
Marketing as; “ creating, communicating, and delivering health information and inter-
ventions using customer-centered and science-based strategies to protect and promote 
the health of diverse populations (Centers for Disease Control and Prevention 2005). 
 
Bernhardt (2006) states that, in essence the work of Health Marketing aims towards 
achieving a world in which every person uses and is provided with accurate, accessible, 
relevant and timely health information, in order to promote and protect their own per-
sonal health, as well as the health of their communities. (Bernhardt 2006) 
 
And due to the development of the Internet and the continuous growth of emerging 
technologies; the utilization of various forms of Mobile Health technologies, services 
and applications has steadily become more apparent within the Health and Medical 
markets. (Foh 2011; Lindqvist et al. 2009).  
 
Amongst these is Mobile Health (mHealth), which in essence is meant for the purposes 
of mobile communication technologies, in the context of medical and healthcare deliv-
ery and assistance, i.e. the provision of health and medical information services via 
mobile technologies (WHO 2012). 
 
Mobile based health and medical marketing efforts can be seen as possessing valuable 
opportunities for enhancing communication and providing improved services to the 
consumers. According to Foh (2011: 3); 
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“ Mobile health can help create a powerful direct to consumer channel previously 
unavailable to pharma marketers. The ability to reach out ... to both consumers 
and healthcare professionals, paired with increasing sophistication of smart 
phone capabilities, is invaluable in an environment of increasing regulation and 
marketing noise. “(Foh 2011: 3) 
 
Mobile phones, smartphones and other technologically advanced mobile devices in 
particular are becoming increasingly present, world-wide. Thus, enabling scenarios and 
potential insights into assessing, as well as improving health. Very notable is the fact 
that, regardless of the socioeconomic group in question, mobile phone usage has been 
widely adopted amongst virtually all demographic groups. And when considering the 
high level of penetration, in regards to computing capacity in mobile phones, the as-
sumption can be made that especially mobile types of technology advancements may 
contribute in changing health and medical information and service delivery. Due to the 
fact that these technologies enable improved data accessibility and availability, in 
terms of for example medication and health guidance or for direct instructions and 
assistance for both maintenance and enhancement of overall health. (Office of Behav-
ioral and Social Sciences Research 2012).  
 
This demand for increasingly electronic, and especially mobile healthcare and informat-
ics, has exceeded the actual science that would be required to actually comprehend 
the possible risks or benefits that these may oppose. This phenomenon can mainly be 
seen in the form of various medical, health or lifestyle “apps”, which have emerged 
throughout recent years and have become increasingly popular and wide-spread. (Of-
fice of Behavioral and Social Sciences Research 2012). 
 
This growing trend is also reflected in recent estimates, concerning the growing popu-
larity of health related apps. According to a recent report by Juniper research, there 
will be a predicted 44 million downloads of health apps onto mobile devices, by the 
end 2012. The report continues to predict that the number of downloads will reach 142 
million, by 2016.  According to the report, the acceptance of newer forms of healthcare 
practices, such as remote patient services, will be directly influenced by the fact that 
consumers are becoming more and more engaged through their mobile devices. 
(iHealthbeat 2011; Juniper Research 2011) 
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Figure 7.  Pharma company initiatives by type, 2006-2009 & 2010. Model adapted from 
Ernst & Young (2012). 
 
 
This rapid expansion of health and medical apps has clearly been noted by the Pharma 
businesses as well, and can also be seen in the investments that Pharmaceutical com-
panies are placing in them, specifically in smart phone apps. According to Ernst & 
Young (2012), the initiatives concerning smart phone health and medical apps, has 
steadily become one of the main investment areas, as illustrated in Figure 7. (Ernst & 
Young, 2012) 
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Figure 8.  Pharmaceutical Value chain. Model adapted from Foh. (2011:4) 
2.2.4 NFC and the Pharmaceutical Value chain 
 
 
Several applications that are currently available, amongst these NFC and RFID technol-
ogies, which have been especially developed and utilized in order to assist with the 
processes throughout the whole of the value chain (Figure 8.), such as drug authenti-
cation processes or production and logistics support (Foh 2011: 2-5; Jara et al. 2010) 
 
 
 
 
 
 
Even more so, NFC technology in particular possesses vast possibilities for bringing 
information and messages across to consumers via point-of-purchase and post pur-
chase communication and services (Lindqvist et al. 2009). This on the other hand can 
be considered as especially relevant in regards to providing medical and healthcare 
related information. 
 
An NFC enabled system, such as the example solution studied in this research, could 
possibly support several steps and functions of the value chain, the most apparent 
functions could include the support provided to Marketing and Sales, Distribution and 
Post-Sales. For example in terms of Marketing and Sales support, an NFC technology 
based intelligent mobile application could enable several functions, such as mobile 
medical and health education and support in conveying different forms marketing 
communication messages. In terms of distribution, the system could provide several 
beneficial services to the users, such as drug compliance information, dosage instruc-
tions and support concerning drug related side effects, in accordance with the individ-
uals personal health and medical information, if indeed these solutions and systems 
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were to be linked with the individuals medical and health data. Also, similar functions 
could be enabled within the post-sales support, these kind of mobile solutions could 
assist the users immensely, for example via aiding in correct and safe usage of the 
drugs, in the comfort of the individuals own surroundings (Foh 2011: 2-5 ; Jara et al 
2010). 
 
Novel NFC mobile solutions, such as the Pharmaceutical Information System, could 
prove to be of very high value, for example in terms of savings regarding national 
healthcare costs and expenditures. An example for this is a survey conducted by the 
Association of Finnish Pharmacies and PricewaterhouseCoopers, which states that the 
free professional services offered by the pharmacies and pharmacists save more than 
half a billion Euros of healthcare costs, annually. The survey included evaluation over 
how much saving were enabled via the free services offered by the pharmacies i.e. 
advice checking over prescriptions, drug interaction information and general health 
advice. According to the survey, these savings amounted up to approximately 565 mil-
lion Euros (€), annually and according to the president of the Association of Finnish 
pharmacies, Mr. Vidgrén, these savings amount to higher sums than the actual share 
of all medicine sales, by the pharmacies in Finland. (Association of Finnish Pharmacies 
2010)  
 
Arguably, some of these very same functions could be handled by the implementation 
and synchronization of for example already existing Electronic patient databases 
(KanTa 2012a) and NFC enabled system solutions. 
 
Section 2.3 will cover relevant theories and findings, concerning consumer behavior, as 
well as what may be the key considerations for marketers or business, when trying to 
determine consumers’ decision making and adoption processes, and acceptance to-
wards technology i.e. assessing factors involved in the possible introduction, adoption 
and usage of NFC technology. 
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2.3 Consumer Behaviour 
 
 
 
Understanding consumer behaviour can be considered as one of the most paramount 
issues in marketing. More specifically, what lies behind the actual purchasing decision 
of a consumer and understanding why consumers decide upon buying a specific prod-
uct or service (Egan 2007 : 53). 
 
The way that consumers behave and act, and how they decide upon purchasing or 
even not purchasing products and services is influenced by several different factors. 
Not all consumers or consumer groups follow the same mannerisms and patterns, and 
marketers need to be aware of, and consider cultural, social, personal and even psy-
chological factors, when embarking in the process of understanding consumer behavior 
(Kotler et al. 2005: 256-266). 
 
 
2.3.1 Decision making process 
 
 
Consumers’ decision making can be influenced by several factors or stages, which in 
joint action can contribute to the final decision over purchasing the actual product or 
service. According to Egan, the simple buying model describes these different stages 
that a consumer may go through, when engaging in said decision making process. The 
simple buying model consists of six individual stages, illustrated in Figure 9. (Egan 
2007 : 53-55) 
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1.  The initial stage of the model is the Problem recognition stage; this stage is con-
sidered as trigger for the initiation of the process. It may be caused by a specific per-
sonal need or even due to an external trigger, such as awareness over new infor-
mation. 
 
2.  The second stage can be considered as the possible next step taken from the initial 
stage. The Information search stage is where the consumer gathers the necessary 
and relevant information concerning the product or service in question. 
 
3.  After the information is obtained, the consumer may move to the third stage, the 
Evaluation. Where the consumer evaluates and judges the alternatives they are pre-
sented with, in regards to the information they have obtained. 
Figure 9.  Simple Buying Model. Adapted from Egan (2007 : 54) 
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4.  After the evaluation, the consumer may now go through the fourth stage - the De-
cision. In this stage the consumer decides over the actual purchase.  
 
5. Once the decision has been made, the consumer will move on to the fifth and se-
cond last stage, The Purchase. Arrived at this stage, the consumer has presumably 
gone through the previous stages and has completed the transaction of purchasing a 
product or service.  
 
6.  Last but not least, is the final stage Post-purchase evaluation. In this stage the 
consumer may decide over the re-purchase of a product or service, or they may en-
gage in further post-purchase information search or evaluation. Behaviour in the last 
stage is also dependent on the level of satisfaction or dissatisfaction the consumer may 
possess, regarding the purchased product or service. 
 
However, according to Egan, one must use the model with sense and understand the 
fact that it is merely a model and that in reality redundancy could and will occur, dur-
ing any of the six stages of the model. Since the model is based upon the assumption 
of consumer’s possessing faultless information regarding the products or services in 
question. (Egan 2007 : 54). 
 
According to Kotler et al (2005), before the consumers actually decide over different 
products or services, they evaluate the different alternatives that they are presented 
with. During this evaluation process various product attributes and features that the 
consumers are presented via the products or services in question come in to play. They 
initially determine the possible value that may be gained from the acquisition of said 
products or services. Kotler et al, state that the evaluation of alternatives can either be 
very extensive at times or in certain cases rather spontaneous or quick (Kotler et al. 
2005: 282-283). The consumers’ decision to purchase products or services often var-
ies, not all decision are extensively planned and the decision process can be affected 
by for example the purchasing environment or in-store marketing direct and advertis-
ing (Solomon et al. 2006: 323-328). In terms of novel solutions, such as NFC technolo-
gy, it is crucial understand and be aware of how and where people engage in the steps 
of the decision process, and what tools they use to aid in them in process.  
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Thus, rather important to note that especially smart phones have nowadays become 
an indispensable information gathering and buying tool, and are threfore used across 
various channels and throughout the research and decision making process. Infor-
mation seeking is conducted by virtually all smartphone users and consumers are 
ready to act based upon the information they receive (Google 2010). For the business-
es and marketers, the widespread adoption of smart mobile devices presents vast op-
portunities, in terms of reaching and servicing consumers, at any given time and place. 
 
According to Kowatsch et al. (2011), the product information provided in purchase sit-
uations can largely influence purchase behaviour. Especially in online purchase situa-
tions, where the usage of online recommendation agents increases the value of prod-
uct information, as the information becomes more adaptive and relevant to the con-
sumers needs. (Kowatsch et al. 2011: 226-239) 
  
Therefore, especially mobile devices, with internet access and various other capabili-
ties, posses the capability to change consumer buying experiences, as well as the re-
spective marketing efforts. Due to the fact that consumers are nowadays able to quick-
ly search for information, evaluate offerings and conduct purchases, across multiple 
platforms. Such as web based and mobile channels, which offer more benefits in re-
gards to consumer convenience, flexibility and personalization (Persaud & Azhar 2012). 
 
This change in behaviour can also be seen in Finnish consumer markets, according to a 
survey published by Statistics Finland, internet usage outside home and work is be-
coming ever more common in Finland, and when comparing the statistics to the overall 
internet use prevalence amongst countries in Europe, Finland is ranked closer to the 
top (Statistics Finland 2011a). 
 
The survey (Figure 10.) states that, the internet has become a daily tool for the majori-
ty of people, an estimated 89 % of the population between the ages of 16 to 74 use 
the internet. Out of these 75 % use the internet on a daily basis and 59 % usually use 
the internet several times a day. Especially relevant is the fact that, devices suitable for 
out of home and work internet usage, such as smartphones, are becoming increasingly 
widespread. According to the survey, already in 2011, 42 % of the population were in 
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Figure 10.  Prevalence of Internet usage and certain purposes of use - Finland, 
2011. (Statistics Finland, 2011a). 
possession of smartphone. And the use of the internet on the move is as well becom-
ing increasingly more common, with 33 % of the population, between the ages of 16-
74, being users of the internet outside their homes and work. And according to the 
survey, Internet is mostly used for everyday matters, such as information search and 
communication purposes. (Statistics Finland, 2011a)  
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This indicates that businesses need to be aware of the technology usage of the con-
sumers. As well as how the consumers may behave and act in regards to point of sale 
communication or how they possibly engage in pre-purchase search queries. And what 
other mediums do the consumers typically use for information gathering, evaluation 
and ultimately decision making, whilst engaged in different steps of the decision pro-
cess. Understanding these factors can be of large aid, when deciding over the correct 
processes, methods and channels, later on used to inform the consumers over for ex-
ample novel NFC technology solutions. 
 
 
2.3.2 Adoption of Innovations  
 
For the purposes of understanding new product and innovation acceptance, and con-
sumers behavior towards these innovations, Rogers in his theory of innovation diffu-
sion defined the process how new developments or innovations enter the markets over 
time and space (Rogers 1995: 5-12). Innovation diffusion theory is based upon the 
assumption of how innovations spread, from the initial source and thenceforth along 
the different consumer groups.  Rogers defines an innovation as “an idea, practice, or 
object perceived as new by an individual” and that "diffusion is the process by which 
an innovation is communicated through certain channels over time among the mem-
bers of a social system." (Rogers 1995: 5-12) 
 
The previous section examined theory concerning general decision making, however 
there can be considered to be notable differences between the buyers decision making 
process for existing products and the decision making process for new products or so 
called innovations. Understanding the theory behind the processes is crucial, since this 
research examines the introduction possibilities of an innovative novel solution, to the 
consumer markets (Kotler et al. 2005). 
 
According to Kotler et al., a new product can be defined as a good, service or idea that 
is perceived by a potential customer as something they may have previously not been 
aware of, i.e. something new or innovative. The so called new innovations may have 
been already available for some time. However the main focus is on understanding 
how the consumers learn about the product or service for the first time and then move 
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Figure 11.  Adoption Process. Model Adapted from Kotler et al. (2005: 287).  
on to the decision over whether or not they decide to adopt these. In marketing, it is 
of paramount importance to understand the process of how a consumer comes to 
know about a product or service. Kotler et al. (2005) have adopted the original diffu-
sion theory of Rogers, and defined this as the adoption process. “Adoption is the men-
tal process through which an individual passes from first hearing about an innovation 
to final adoption, and adoption as the decision by an individual to become a regular 
user of the product”. (Kotler et al. 2005: 287) 
 
These stages in the adoption process are explained as follows (Kotler et al. 2005: 287): 
 
 
1.  Awareness : the initial stage is when the consumer becomes aware of the new 
product, however they are still lacking information about it. 
 
2.  Interest : in the stage of interest, the consumer moves onto seeking information 
about the product. 
 
3.  Evaluation : in the stage of evaluation, the consumer is now faced with the deci-
sion of whether or not trying the new product even makes sense. 
 
4.  Trial : in the stage of trial, the consumer tries the new product, on a smaller scale 
of implementation, in order to improve their estimates in regards to the values offered 
by the product. 
 
5.  Adoption : the final stage adoption, is when the consumer decides upon full, as 
well as regular usage of the new product. 
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The adoption process model suggests that marketers, who are engaged in new-
product marketing, should consider thinking about how to aid the consumers in moving 
along these stages. This can prove of great advantage in terms of understanding con-
sumer behavior and needs. Due to the fact that understanding why consumers may be 
willing to move onto certain stages, but are not willing to pass through the whole pro-
cess, could possibly offer valuable insights into how specific products should be mar-
keted and offered, and what kind of optional or differentiated services and methods 
should possibly be included in the marketing and sales process (Kotler et al. 2005: 287 
; Rogers 1995).  
 
However, according to Kotler et al., one must consider the individual differences in 
innovativeness, in order to be aware of the differences amongst the consumers in their 
readiness of trying new products. Since the adoption of new products varies from indi-
vidual to individual, one can consider there to be in each product area the so called 
“consumption pioneers” and “early adopters”, that are willing and able to adopt new 
products in a more quicker fashion, than the rest of the consumers. (Kotler et al. 2005: 
287) 
 
This on the other hand has led to consumers being classified and placed into specific 
categories, on the basis of the relative time they are able and willing to adopt the new 
products, the so called Adopter categories (Kotler et al. 2005: 287-288). 
Understanding these individual groups and their behavior is of high importance, in or-
der to be able to effectively market the new innovations. And furthermore, understand-
ing these groups and ultimately effectively targeting and customizing marketing efforts 
and messages to the right set of consumers, is of utmost importance to this specific 
research paper and its exploratory nature (Kotler et al. 2005: 287-288). 
 
Accordingly, the consumers are hence categorized into five different types or groups, 
illustrated in Figure 14. However, in regards to this research, one may consider that 
the most important groups are the innovators and early adopters, due to the previously 
unprecedented nature of such novel NFC enabled solutions, amongst consumer mar-
kets. Nevertheless understanding the traits and behavior all other consumer groups is 
still vital and relevant, for the evaluation of consumer behavior and decision making 
processes (Kotler et al. 2005). 
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Fig.12  Diffusion of Innovations. Rogers (1995). Figure Adapted from Kotler et.al 
(2005: 288).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
According to Kotler et al. (2005), the first group, the Innovators, are considered as 
being the consumers adopt any new product or idea that enters in to the markets with 
a faster rate than others. These types of consumers are typically status conscious peo-
ple that are willing to try out new ideas, even with the possibility of encountering cer-
tain risks. Therefore the marketers need to pay attention in highlighting the possible 
esteems or benefits brought on by the new products, in order to make them more ap-
pealing to this group of consumers. (Kotler et al. 2005: 287-288) 
 
The Early adopters, are categorized as being the type of consumers that are usually 
the opinion leaders within their communities. Therefore they are slightly more hesitant 
and considerate towards adopting the new products, nevertheless at the same time, 
due to their knowledge and skills, they are able to exert their influence on to other 
consumers. Thereby also aiding in the development of the adoption process.  
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The Early majority consists of the group of consumers, that are rarely the opinion 
leaders, but nevertheless this category of the consumers is still more likely to adopt the 
new products or ideas before the average consumers. 
 
The next category is the Late majority, these consumers are highly skeptical of the 
new products or ideas and are therefore more likely to adopt them after the majority 
of consumers are already acquainted with the new products or ideas. 
 
The last group of the consumers are the Laggards, these consumers are more tradi-
tion oriented and are more likely to adopt the new products or ideas very slowly and 
hesitantly, preferably after these new innovations have already become widely accept-
ed and acknowledged. (Kotler et al. 2005 : 288 ; Rogers, 1995) 
 
These adopter classifications and the their individual rates of adoption become even 
more so important when dealing with highly innovative and new products or services, 
as is the case with this particular research. Since these types of scenarios the market-
ers need to be able to identify and effectively target the opinion leaders, in order to 
establish preliminary grounds for mass approval and awareness over the new ideas, in 
order to ultimately convince the late majorities as well as laggards of these new ideas 
(Kotler et al. 2005 : 288-289). There are several other factors and considerations that 
need to be taken into account regarding consumers’ adoption of new products. One 
key consideration is how the actual characteristics of the new products influence the 
rate of adoption. According to Kotler et al. (2005) “some products can catch on almost 
overnight, whereas others take a long time to gain acceptance.” (Kotler et al. 2005: 
289) 
 
When considering the influences on the rate in which an innovation is adopted, accord-
ing to Kotler et al. there are five specific characteristics that need to be considered  
(Kotler et al. 2005: 289); 
Firstly, the relative advantage, meaning the degree to which the innovation appears 
superior to the already existing offerings. Thus the greater the relative advantage of-
fered, the earlier the innovation will be adopted.  
Secondly, the compatibility, which means the degree to which the innovation suits the 
specific values and preset experiences of the consumers. 
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Thirdly, complexity, the degree to which the innovation may prove to be difficult un-
derstand or even use.  
Fourthly, divisibility, the degree to which the innovation may be tried or used on small-
er scale scenarios.  
And lastly, communicability, the degree to which the usage results and experiences 
may be observed or passed along to other consumers.  
 
Besides these factors, there are several other variables that may influence the rate of 
adoption, for example costs, risks, social approval and the exerted influence by the 
opinion leaders. Therefore, in the process of new product marketing, one must consid-
er and research all the underlying and influencing factors, in order to establish a func-
tioning marketing strategy, which can be used to aid and enhance the adoption pro-
cess of the new innovations. (Kotler et al., 2005 : 289) 
 
In terms of NFC technology adoption, there is very little to no research available.  
However, there are some studies that have research this phenomenon, of which the 
majority have been focused on the concept of privacy. Thus, privacy issues have been 
identified as being a major practical implementation challenge and as the most signifi-
cant cost to consumers (Uhrich et al. 2008; Sill et al. 2008). The attitudes that the con-
sumers’ possess towards the privacy issues, has been found to directly influence the 
propensity to purchase NFC or RFID tagged products. These findings imply that, the 
more value and importance consumers place upon privacy, the less likely they are to 
adopt NFC or RFID technology in retailing. However, it was also found that when NFC 
or RFID technology is involved, consumers seemed only moderately privacy aware 
(Crazier et al. 2008; Rothensee & Spiekermann 2008), this on the other indicates that 
the consumers might in fact be willing to accept the use and implementation of NFC 
technology in Marketing efforts (Boeck et al., 2011). 
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2.3.3 Technology acceptance 
 
 
For the means of understanding the theory behind consumers’ acceptance and willing-
ness to use technology, there are various different user acceptance models that have 
been proposed in the field of information and computer technologies. The main intent 
behind these theories is to measure actual user acceptance, in regards to new or inno-
vative technology variations, as well as to predict and identify possible issues concern-
ing the usage of said innovative technologies. Understanding some of basics behind 
these theories can be considered relevant to this particular research, since the effects 
of NFC technology and the possible acceptance of these technologies, such as the ex-
ample solution examined in the last chapter, can up to date still be considered as as-
sumptions, due to both their lack of research and implementation within the consumer 
markets. 
 
For the purposes of this research, one model in particular, can be considered as rele-
vant in determining factors involving technology. The Technology acceptance model 
(TAM) is the most acknowledged and most widely used model, originally proposed by 
Davis, in 1986. Davis adapted the idea of TAM from Fishbein & Ajzen’s initial theory of 
reasoned action (TRA) proposed initially in 1975, which is intended for the purposes of 
studying user intentions towards accepting information technology (Davis et al. 1989; 
Venkatesh et al., 2003.). 
 
The main purpose of the TAM model is to predict user behavior, in regards to comput-
er technology usage. The model consists of two key variables, firstly the perceived 
usefulness of particular system and secondly the perceived usage of said system (Davis 
et al. 1989; Venkatesh & Davis 2000). 
 
The assumption is that if and when the user believes that the particular system in 
question can be of aid and assist them in performing a function or task, then the users 
behavioral intention to forth on use the particular system is accordingly being positively 
influenced. Also, once the system is perceived as useful and the user is being positively 
influenced by the system, the users’ behavioral attitudes towards continued usage can 
as well be considered as more probable (Davis et al. 1989; Venkatesh & Davis 2000). 
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Figure 13.  Technology Acceptance Model. Adapted from Davis et al.(1989). 
 
 
 
 
 
 
 
 
 
 
The model suggests that the perceived ease of use also directly influences the level of 
perceived usefulness, in the sense that once a system is perceived as being too com-
plicated and in some ways unusable, the user is directly inclined towards categorizing 
the system as non useful, thus the user is more likely to dismiss the system completely 
(Davis et al. 1989; Venkatesh & Davis 2000). 
 
The users’ attitude towards the system is of utmost importance, since the attitudes 
directly influence the levels of behavioral intentions, which are considered as being the 
main indicator for predicting end and continued usage (Davis et al. 1989; Venkatesh & 
Davis 2000). As illustrated in Figure 13, the models core beliefs or variables are con-
cerned with the influences on user adoption and end usage of information technology. 
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The technology acceptance model specifies the causal relationships between system 
design features, perceived usefulness, perceived ease of use, attitude toward using 
and actual usage behaviour. Overall, TAM provides a representation of the mechanisms 
by which design influences user acceptance, and could therefore be helpful in forecast-
ing and evaluating user acceptance towards technology. (Davis et al. 1989; Venkatesh 
& Davis, 2000; Lee et al. 2003) 
 
Research has found that the influences of perceived convenience, perceived culture 
and perceived security to have a significant impact on the consumer’s willingness to 
accept NFC or RFID technology. The perceived convenience has a positive effect on 
the consumers intention to use the technology, thus this would indicate that the higher 
the perceived convenience factor of NFC technology, the greater the consumers inten-
tion to use the technology.  Also, the influence of culture on the consumers percep-
tions about NFC or RFID technology, is as well a significant factor for determining the 
consumers acceptance towards the technology. In other words, the extent to which 
the consumer accepts the technology is directly influenced by their individual beliefs, 
values, norms and behavior. Another crucial determinant for consumer acceptance of 
NFC technology is the perception of having information security. It was found that the 
higher the importance of possessing information security, and the lower the willingness 
to make compromises regarding these factors, ultimately the lower the actual intention 
to use NFC or RFID technology (Ohkubo, Suzuki & Kinoshita, 2005 ; Hossain & 
Prybutok, 2008). 
 
The following chapter will illustrate the novel concept solution, which has been used as 
both the basis for this research, and as a practical example of the capabilities and pos-
sibilities of NFC technology solutions in Pharmaceutical products and services.  
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3 PHARMACEUTICAL INFORMATION SYSTEM (PIS) 
 
 
If to become reality, the possible benefits for the Pharmaceutical companies, Pharma-
cies, Governments and most importantly for the consumers, resulting from the utiliza-
tion of such proposed novel solutions as the Pharmaceutical Information System (PIS), 
could be rather wide ranging. With the assumption, that if such a solution would in fact 
able to decrease the amount of for example adverse drug reactions, drug misusage or 
drug allergies, by enhancing both the purchase and post-purchase process of pharma-
ceuticals. Then the economic, financial and social benefits to the society at large could 
assumedly be rather vast. According to the EU; 
 
“Medicinal products contribute considerably to the health of EU citizens. They 
can, however, also have adverse effects. It is estimated that 5% of all hospital 
admissions are due to an adverse drug reaction (ADR) ... It is estimated that 
197,000 deaths per year in the EU are caused by ADRs and that the total cost to 
society of ADRs in the EU is € 79 billion.“ (European Union 2008) 
 
Even though the aforementioned ADR cases and their background specifics are not 
stated by the EU, and therefore could have resulted from various reasons. The fact 
remains that, if this type of solution could even slightly minimize such incidents and 
occurrences, there would arguably be sufficient enough causality and reason for the 
development and end implementation of such technological solutions. 
 
After all; “Improving quality assurance and providing effective healthcare are some of 
the most important aims of information and communication technologies”.  (Jara et al., 
2010) 
 
3.1 The PIS 
 
The PIS is an assisted living solution i.e. personal drug checker, proposed by Jara et al. 
(2010), for the purposes of solving issues concerning adverse drug reactions, drug 
compatibility and allergy detection. The system process can be explained as follows, 
once the drug(s) have been identified via the NFC enabled device and NFC tag interac-
tion, the information over this is sent to the PIS, which the commences in matching the 
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ingredients of the drug, with the individual users allergy profile and health records, in 
order to detect and prevent potential reactions. The system uses frameworks to model 
the user profile and drugs, in order to apply rules, which detect side effects and poten-
tial problems, related to the ingredients in the drugs. The information regarding these 
can be accessed by the user via a specifically designed easy to use interface on the 
mobile devices terminal. (Jara et al., 2010) 
 
The PIS itself is composed of three parts, a drug database that was synchronized with 
a national Pharmaceutical database, a knowledge-base system and a rule engine sys-
tem (Jara et al. 2010). The Knowledge base system, proposed and implemented by 
Jara et al., represents firstly the subjects allergies and secondly the drug information 
from the database, therefore it is able to detect issues relating to drug interactions, for 
example a drug is consumed by the subject is categorized and classified by the system 
as having certain side-effects if consumed simultaneously with a another substance or 
drug, the system identifies this and advises the subject over the possible adverse in-
teractions of the two drugs or substances, and thenceforth commences in recommend-
ing an alternative drug, which would be compatible with the original substance con-
sumed. After the individual patient profile has been defined and the information over 
the subjects drugs is implemented onto the system, the rule engine system is then 
after used in order to detect the possible ADR’s, allergies and other drug interaction 
variables. (Jara et al. 2010) 
 
With the use of NFC technology, the application solution is able to provide extended 
information about drugs, explaining for example why a drug may not be compatible 
with the subjects’ profile. The PIS matches the drug ID with its knowledge-base and 
the patient’s profile, and displays an answer on for example the smartphone of the 
user, thus informing whether or not the drug in question is safe for usage. For the 
identification of the drugs, NFC tags were implemented onto the drug packaging’s 
(Jara et al., 2010). The first window of Figure 14 displays an example of the subjects 
currently used drug’s incompatibility or side effects associated the simultaneous usage 
alongside with Aspirin. Additionally, the smartphone solution enables the user to define 
and update their own profile, illustrated in the middle window of Figure 14. The third 
window of Figure 14 shows the intuitive interface, which enables the users to update 
their profiles. (Jara et al., 2010) 
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For the test solution itself, Jara et al. added an NFC/RFID tag to each drug package. 
This tag contained a unique ID, in order to identify each individual drug, without any 
doubt or errors. Illustrated in the first window of Figure 15 is one of the drug packages 
with the NFC/RFID tag implemented onto the upper right corner of the package. (Jara 
et al., 2010) 
 
 
Fig.14 Left: Drug extended information. Middle : Patient profile. Right : editing infor-
mation.  Jara et al. (2010) 
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The test solution was carried out using a pocket PC, illustrated in the second window 
of Figure 15. This device used an external NFC reader device implemented onto the 
device, in order to read the data from the tag. An NFC reader/writer mode enabled 
device such as an NFC enabled smart phone, would have been able to perform the 
same tasks, without the need for external devices. As illustrated in the second window 
of Figure 15, the device is placed in close proximity of the tag, after which the PIS en-
abled device then reads the tag and commences wireless intercommunication i.e. data 
retrieval and analysis. (Jara et al., 2010) 
 
The PIS was tested with a patient, with a pre-existing drug regimen and an allergy 
profile, this means that when and if the patient were to take simultaneously another 
drug or substance that would collide with either the drugs or the individuals profile, the 
system would be able to detect and present this information. (Jara et al., 2010) 
The system was designed in a flexible way, in order to enable extensions to other mo-
bile platforms, as well as other identification technologies. 
More importantly, the applicability in the real world can be considered as direct, since 
the drug database of the system was directly synchronized with a national health and 
Fig.15 Identifying pharmaceuticals, using NFC technology. Jara et al. (2010) 
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medical database, in the case of this solution, Jara et al., synchronized the system with 
the Spanish Pharmaceutical Associations database, which enabled the system to take 
full advantage of all current and future drug information. (Jara et al., 2010) 
Similarly, in Finland the system could hypothetically be synchronized with The National 
Archive of Health Information (KanTa), which is the collective name for several nation-
al medical and healthcare information systems in Finland. Including, the electronic ar-
chive of patient records and information or eArchive. (KanTa 2012a) 
The eArchive grants centralized access to the patient’s medical health records, howev-
er only with the permission of the patient. Thus unifying and enhancing the transfer of 
patient data and information across all units, organizations and platforms. The 
eArchive acts as a final and central archive for all the patient information. The system 
also allows all patients over the ages of 18 to access personal information online, 
which is stored in the electronic archive of patient records. Therefore the individual is 
able to check and review their personal health and medical information, without re-
strictions, once these have been stored in the electronic archives (KanTa 2012b). The 
systems will be implemented in stages and to all public and private sector care provid-
ers, pharmacies and citizens in Finland. All healthcare and medical units nationwide will 
have to implement the KanTa services by the end of 2015. (KanTa 2012b) 
 
 
3.2 The PIS and the possible future of OTC Pharmaceutical Markets 
in Finland 
 
 
The inclining price indexes (noted in section 2.2.1) is one of the main reasons as to 
why OTC medicines can be considered as becoming increasingly more interesting for 
the actors within the Pharmaceutical industry. Thus many of the Pharmaceutical com-
panies are now seeking for increased growth, especially through OTC medicine mar-
kets. Due to the fact that the prescription medication markets are more competitive 
and the prescription medication pricing levels are monitored and controlled by the gov-
erning authorities, whereas OTC medication pricing is up to the companies themselves. 
(Fimea 2010a; Pharma Industry Finland 2010e; Pharma Industry Finland 2008) 
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One aspect that could completely alter the current markets, as well as communication 
and service efforts, and increase the availability and sales of OTC pharmaceuticals in 
Finland, is the fact that the Finnish Daily Consumer Goods Trade (PTY) is currently 
lobbying for modifications in current laws and legislations, which if passed would give 
convenience stores the legal right to sell all OTC pharmaceuticals. Thus, possibly re-
placing many of the current pharmacies as main sales outlets. According to the PTY, a 
change of this magnitude would enable both improved accessibility and lowered price 
margins for the consumers, as has been the case with other Nordic counties, which 
have allowed convenience stores to sell OTC pharmaceuticals, for example, as of the 
beginning of 2009, Sweden. (PTY 2009; CapGemini 2011: 2) 
 
The efforts by the PTY are now being supported by the Consumer’s Association of Fin-
land, which believes that the current monopolistic markets of the Pharmacies can no 
longer be seen as justifiable (Federation of Finnish Commerce 2011). The Consumer’s 
Association of Finland is now along with the PTY, are demanding that OTC pharmaceu-
tical sales would be allowed through convenience stores as well.  
 
These efforts are however being opposed by The Association of Finnish Pharmacies, 
which claim that the release of OTC drugs into regular stores, would for example com-
promise consumer safety and security, in terms of drug purchase and consumption, if 
the consumers would not be offered sufficient guidance and support by professionals. 
(PTY 2010; Association of Finnish Pharmacies 2009) 
 
This possible future market scenario is where NFC enabled technology solutions such 
as the PIS in OTC pharmaceutical products and services could prove to be of significant 
aid. For example, in the case of medicine purchases from larger convenience stores, 
with possibilities for enhanced usage instructions, such as drug compliance and drug 
interaction information. In this scenario the assumption may be that, for example sales 
through convenience stores might not be accompanied with sufficient professional 
support and advice, such as is the case in pharmacies (Association of Finnish Pharma-
cies 2009), and that in this case these very same support and advisory functions could 
be enabled, if not even managed via utilizing NFC technology enabled smart systems 
and products. (Morrison & Arnall 2011; Lindqvist et al. 2009; Jara et al. 2010)  
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This on the other hand could also constitute significant changes in both general mar-
keting and advertising efforts, as well as a hypothetical increase in health and medical 
based electronic and mobile communications. For example if convenience stores would 
have the ability to sell OTC drugs, the clear assumption would be that, since the con-
sumer base would become much larger, and since OTC drugs are rather lucrative 
products, with the price margins being quite high, that the stores and drug brands 
would be willing to invest far more efforts in marketing the products and services, to 
the consumers at large. If these health and medical products and applications would 
indeed be sold along with “everyday items” (Pharma Industry Finland 2008). 
 
Following from the both literature review and the PIS chapters, the methodology chap-
ter will present the main research questions, objectives and qualitative methods of the 
research.  
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4 METHODOLOGY 
 
 
 
4.1 Research Questions and Objectives 
 
After extensively reviewing various relevant theories and aspects from literatures, pub-
lications, and other materials, primary research needed to be conducted, in order to 
find answers to the research questions;                   
 
“What would be the possible benefits, challenges and ultimately the conceivability of 
utilizing NFC technology in OTC Pharmaceutical products and services?“  
 
In order to answers the research questions, and in order to gather sufficient evidence 
to support the answers, a suitable research approach and method, alongside the litera-
ture review, needed to be selected, These approaches and methods are explained and 
justified in the following parts, along with the data collection and analysis methods and 
procedures. 
 
4.2 Research Approach 
 
The use of theory is involved in any type of research, and the theoretical approach of a 
research can be considered as either inductive or deductive, which both approach and 
propose two slightly different, yet not mutually excluding, ways of drawing conclusions 
(Saunders et al., 2000: 116-120).  
 
When deciding upon what type of research approach to adopt, Saunders et al. (2000) 
suggest a number criteria to be considered. Of these criterions, perhaps the most im-
portant is the nature of the research topic. If there is a vast amount of literature re-
garding the topic, it is most often suitable to use a deductive approach. In opposition, 
when researching a topic that is new and little existing literature or research can be 
found, it may be more appropriate to use an inductive approach (Saunders et al., 
2000: 117-121). 
 
43 
 
Concerning this topic, little to no theory and research is previously available, over the 
implementation, effects and acceptance of NFC technology in Pharmaceuticals, and 
what the possible benefits, issues and challenges regarding the technology and its use 
might be. Due to this, an inductive approach was chosen. Largely based upon the fact 
that the highly exploratory and hypothetical nature of the research is more suited to-
wards this approach (Saunders et al., 2000). 
 
 
4.3 Research Methods 
 
For this particular research, qualitative research methods were chosen, for a number of 
reasons. Firstly, qualitative research methods, in contrast to quantitative, are by nature 
more flexible and versatile. Qualitative methods are designed towards aiding in the 
understanding of people and their contexts. They also emphasize on the description of 
a phenomenon, and attempt to explain the residing relationships in a deeper and de-
tailed manner. Whereas quantitative research methods are considered as less flexible, 
due to their often standardized measures, used in order to validate and generalize the 
experiences and perspectives of people.  
Secondly, qualitative research should be applied if a phenomenon or topic is new and 
innovative, and since the wider scope of NFC technology related services and systems 
is as of current considered as an emerging and rapidly developing field, a qualitative 
research approach can be considered as more suitable. (Hirsijärvi & Hurme 2004: 21-
32) Thirdly, in order for quantitative research methods, such as questionnaires to pro-
vide results for this study, the participants should preferably posses some level of pre-
vious knowledge over either Pharma or NFC. However, fact of the matter is that the 
overwhelming majority of people do not possess the necessary knowledge over NFC 
technology, especially when researching this in the context of Pharmaceutical products 
and services, therefore quantitative methods were excluded (Hirsijärvi & Hurme 2004: 
21-32). And lastly, quantitative research methods were ultimately excluded due to 
availability of resources and materials, i.e. NFC concept solution and pharmacy testing 
environment. Due to the fact that in order to properly assess acceptance and usage of 
NFC based applications, and in order to obtain any relevant research insights, one 
would have had to preferably develop these currently un-existing solutions, in order to 
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allow the participants to physically test and assess these applications (Hirsijärvi & 
Hurme 2004; Saunders et al. 2000). 
 
For this research, semi-structured, personal interviews, with an explorative nature were 
chosen. Semi-structured interviews are more suitable for this research, since these 
allow more customization, context adaptation in accordance with the particular inter-
viewee and interview situation. When conducting semi-structured interviews, the re-
searcher may have preset a list of themes and questions to be covered, however with 
the possibility to adopt, vary and add questions based upon the nature or flow of the 
individual interviews, in order to further improve the amount of relevant insights to be 
gained. Having some preset structures, themes and questions also allowed to collect 
more relevant material, in the realms of the given topic, thus the collected materials 
would also vary according to the interviewee’s personal and professional opinions, 
nevertheless remaining relevant to this research (Saunders et al., 2000: 311-313; 
Hirsijärvi & Hurme 2004: 21-32). 
 
Also, personal and in depth interviews were chosen due to the advantages they would 
offer, in regards to this particular research topic and its questions. The advantages of 
personal interviews over for example group interviews, is a higher level of control over 
the end outcome, the avoidance of individuals influencing each other and the possible 
dominance of one individual over others within the group. In other words, personal 
interviews may produce more honest answers. This approach was mainly chosen in 
order to gain deeper and far reaching knowledge over various relevant factors and 
topics, such as the OTC Pharmaceutical markets, marketing practices, the consumers, 
as well as NFC technology (Saunders et al. 2000: 311-316 ; Daymon et al., 2004). 
 
 
4.4 Data Collection 
 
For the means of qualitative research, the selection of participants is of utmost im-
portance, in order to further increase the value of the research. Qualitative research 
and especially one with an exploratory approach is more aimed towards investigating a 
phenomenon. Thus, not every person can be considered as suitable to contribute to 
the research, with their knowledge and experience (Hirsijärvi & Hurme: 58-63; Saun-
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ders et al., 2000 ; Daymon et al., 2004).For qualitative research it is not a must to in-
clude a wide range of participants, since qualitative research cannot generalize that 
much to a wider population, but it may instead take advantage of participants with 
specific presets of knowledge and relevant experience, in order to better explore a 
phenomenon and the relevant factors or considerations that may be involved (Hirsijärvi 
& Hurme: 58-63; Daymon et al., 2004). 
 
Primary research based upon qualitative interviewing is considered to be able to obtain 
enough information from a smaller number of participants. However, the amount of 
relevant and meaningful information gained also depends on the knowledge and con-
tribution of the participants. Therefore, the participants were carefully selected, ac-
cording to their function, position and experience within relevant fields and markets, in 
regards to this research topic, and the perceived value and meaning they would be 
able to contribute to the research (Saunders et al., 2000 ; Hirsijärvi & Hurme, 2004). 
Due to the limited time scope of the thesis, four participants were chosen.  
Nevertheless, Kvale states that the knowledge and information obtained through inter-
views compensates for the smaller sample size that these may constitute (Kvale, 
1996). 
 
The criteria was to be able to conduct personal interviews with people that possessed 
the necessary experience and knowledge about the Pharmaceutical and Health indus-
try, OTC markets, actors and entities within the industry and markets, as well as the 
actual marketing practices and methods of OTC products and services in Finland. And 
also, people that possessed first-hand knowledge and experience over consumer traits 
and behaviour, within the aforementioned frameworks. 
 
Four personal interviews were conducted, two face-to-face interviews and two inter-
views over the phone, with professionals from the Pharma, Medical and Health sectors, 
that the researcher was fortunate enough to gain access to.  
 
Director A - is amongst other functions, the managing director of a pharmaceutical 
marketing company. 
 
Director B - is a director at one of the world’s leading pharmaceutical companies. 
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Director C - is amongst other functions, a director of pharmacology at a specialized 
agency of the United Nations (UN). 
 
Director D - is the managing director of a Medical and Pharmaceutical consulting com-
pany. 
 
Full interviewee profiles can be found in Appendix 1. 
 
As stated previously, the nature of this research was to explore and understand, not to 
confirm, and thus the semi-structured interview approach was chosen. 
The interview structures and questions, illustrated in Appendix 2, were structured ac-
cording to the theory and material examined in the literature review, and therefore 
some of the interview questions were as well to an extent based upon subjects and 
theoretical principles deducted from the literature review.  
 
However with the emphasis in both maintaining a certain structure, yet still keeping 
the questions and structure relatively open, in order to allow subjective answers and 
minimize bias and interviewer effect, and in order to gain more far reaching and broad 
perspectives in regards to the assumptions, theories and questions. Based upon these 
particular approaches and methods, the interview question also included probing, fol-
low-up and clarifying questions, in order to act as an qualitative research aid in the 
interview sessions, however with the emphasis on not being set in any strict or specific 
order (Hirsijärvi & Hurme, 2004: 102-115). This on the other hand enabled to create a 
more natural and free-flowing conversation atmosphere, which in retrospect, positively 
influenced the end outcome of the interviews.   
 
The interview outline was composed of subjects deducted from the theoretical princi-
ples and other findings. However with an emphasis deliberately avoiding too direct 
questions concerning NFC technology, which may have interfered negatively with the 
amount of relevant material obtained from the participants, due to the interviewee’s 
possibly un-presented knowledge and unawareness over NFC technology and its appli-
cation possibilities (Hirsijärvi & Hurme, 2004). 
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All interviews were recorded and transcribed, in order to ensure proper data analysis, 
and in order ensure that all information was retained. This also enabled the interview 
sessions to become more participatory, and allowed the researcher personally to be-
come more attendant, as well as more absorbent towards detailed answers and 
thoughts of the interviewees (Daymon et al. 2004: 179). All data is represented in ac-
cordance with the individual interviewees’ opinions, and are presented objectively. 
 
 
4.5 Data Analysis 
 
When analyzing qualitative data, the separation between conceptualization, categoriz-
ing, analysis and interpretation may often be intertwined, and may also take place 
simultaneously throughout the research process. However, the goal of the data analy-
sis was not to develop a theory, instead the emphasis was on finding causalities, ob-
stacles and the possible conceivability of NFC solutions, within the frameworks exam-
ined in this research (Daymon et al. 2004: 231-232). 
 
The core purpose behind the interviews with Pharma professionals was to gain insights 
over the current and assumed future markets, along with their respective practices. 
Due to the exploratory nature of this research and the lack of previous research, the 
knowledge and input of the professionals was much needed, in order to take into ac-
count various factors, from both the business and consumer perspective. And secondly 
to assess NFC solutions, and how these might or might not fit within the examined 
frameworks, thus attempting to bridge the relation, and correspondence between the 
published material and qualitative findings.  
 
The topics and questions covered in the interviews were derived from the examined 
materials of the literature review, however with the aim of ensuring that neither per-
sonal thoughts nor theory would interfere with the gathered information (Saunders et 
al., 2000). And as previously mentioned, all interviews were recorded and transcribed, 
thus allowing me to go through the material, as many times as necessary. And also to 
examine these in relation to the materials presented in the literature review.  
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5 FINDINGS AND DISCUSSION 
 
 
The core aim of this research was to seek answers concerning the possibilities, chal-
lenges and causalities for the implementation and utilization of NFC technology solu-
tions in OTC Pharmaceutical products and services. In this research, the unit of analy-
sis was the PIS concept solution by Jara et.al, which was used as the practical example 
of NFC technology’s possibilities for Health and Medical Marketing. 
 
Due to the lack of existing research concerning this topic, the need to draw opinions 
and insight from Pharma and Medical professionals was needed, in order to assess the 
possible benefits, challenges, and the actual conceivability of the explored implementa-
tion scenario, and to compare these qualitative findings along side with the findings 
drawn from the literature and other empirical materials; in order to ultimately find vali-
dation for the research questions. 
 
The main findings are presented and analyzed in the following sections. The questions, 
as well as the findings are categorized in accordance with the main sections presented 
in the paper. 
 
 
 
5.1 OTC Pharmaceutical Markets and Marketing  
 
 
The unanimous opinion of all interviewees, respectively, was that OTC Pharmaceuticals 
have become more attractive to Pharmaceutical companies, due to their limited regula-
tions in marketing, sales and pricing, in comparison to prescription Pharmaceuticals.   
And according to Director A, one of the main reasons for the lucrative state of OTC 
pharmaceuticals being the continuously inclining price, sales and profit margins. 
In accordance, Statistics Finland showed that the price of OTC pharmaceutical products 
has continuously inclined throughout the last ten years, with an increase of nearly 30 
%, from the year 2000 to 2011 (Statistics Finland, 2012).  
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Director B stated that since OTC pharmaceuticals are becoming more and more lucra-
tive, and the sales are inclining, the urge for improved and enhanced communication, 
via for example advanced mobile technologies is becoming more apparent and needed. 
 
Another important consideration, brought forward by Director A, is the fact that 
price/quality ratio remains the most important factor, from the consumer’s perspective, 
therefore improved quality or decreased pricing in the products would constitute as 
main selling arguments, over the competing products. And according to Director D, the 
consumers generally are willing to pay more for the perceived quality or superiority of 
the products and services. In accordance, Director B stated, in OTC pharmaceutical 
marketing, the key advantage lies in the marketing of perceptions, in most cases either 
via conveying superior quality or effectiveness. Therefore especially novel products 
need to be accompanied by one of the aforementioned traits. 
And according to Director B, a solution such as the PIS, could in fact constitute as pos-
sessing both traits.  
 
According to Director C and Director D, respectively, another reason as to why OTC 
pharmaceutical sales have increased so dramatically is the fact that the Pharmacies or 
Pharmacists themselves are trying to more actively persuade consumers to buy OTC 
pharmaceuticals. Due to the higher profit margins obtained from the sales of OTC 
pharmaceuticals, in comparison prescription pharmaceuticals. According to Director C, 
thus more effort is actually being placed upon both actively marketing, promoting and 
selling specifically OTC pharmaceuticals to the end consumers. Therefore, any unique 
selling point or perceived advantage offered by specific products, such as containing 
NFC technology, would most likely increase the likelihood of these being both marketed 
and recommended by for example the Pharmacists and doctors. Also, according to 
Director A, the role of specialists in drug recommendation and advice situations is vital; 
therefore it would also be important that the specialists themselves would possess 
some sort of reason or motivation towards recommending for example NFC enabled 
solutions. And according to Director A, the motivation in the case of solutions such as 
the PIS, would clearly be improved customer safety and satisfaction, along with the 
possibility for increased re-purchases. 
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According to Director A and Director D, respectively, this particular research is more 
than current and highly relevant, partly because of the efforts enforced by the PTY, of 
moving OTC pharmaceutical sales to convenience stores and supermarkets.  
According to the PTY, a change in this direction would enable both improved accessibil-
ity and lowered price margins for the consumers, as has been the case with other Nor-
dic counties, such as Sweden. (PTY, 2011 : 10 ; CapGemini, 2011 ; 2).  
 
If this scenario would indeed become reality, according to Director B, several factors 
would become relevant and apparent, especially when considering utilizing novel tech-
nologies, such as the use of the PIS solution in OTC pharmaceutical products and ser-
vices. Firstly, this would mean that OTC drug sales would become more customer cen-
tered. According to Director B, this becomes highly important when considering the 
current situation, where point of sale information and help is provided by professionals 
in the pharmacies, whereas if OTC drugs were to be sold in convenience stores, the 
amount of advice and guidance would most likely be very minimal.  
And according to Director A and Director C, respectively,  this effect can already be 
seen in the selling of nicotine-replacement products, which are sold through conven-
ience stores, and according to both, there are severe limitations and problems in terms 
of consumers receiving sufficient guidance and information, from the stores and their 
employees. This of course would become even more crucial and even vital, when deal-
ing with numerous amounts of present OTC pharmaceuticals, since the amount harm 
that may be caused via for example unwanted drug side effects or ADRs, caused by 
misinformed usage, could be rather vast. 
And therefore, according to Director A and Director B, respectively, especially in these 
situations, the need for NFC solutions, such as the PIS, would become very apparent. 
 
Director A and Director C, respectively, both raised important points, concerning the 
current relevance of mobile marketing, especially in the context of health. They both 
stated that since the Pharmaceutical industry is developing rapidly, and in general 
moving towards more technological based efforts; smart phones and other mobile de-
vices can be considered as valuable tools to convey and communicate marketing mes-
sages across to consumers. Furthermore, according to Director A, health and medical 
applications are becoming ever more apparent, and are constantly being developed. 
This has lead to the consumers being more independent, as well as inclined towards 
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getting medical information and advice through various electronic and mobile platforms 
or applications. And according to Director A, this could in fact indicate that the con-
sumers of today are accepting and willing towards using more advanced technologies, 
such as NFC. Similarly, the growing popularity of for example health related apps can 
be seen in recent estimates. According to recent estimates by MobiHealthNews, the 
number of health related apps will reach over 13 000, by the end of 2012 
(MobiHealthNews, 2011). And according to Juniper research, a predicted 44 million 
downloads of health apps onto mobile devices, will be reality by the end 2012. And 
that the number of downloads will reach 142 million, by 2016. (iHealthbeat, 2011) 
 
Furthermore, according to Director A, the most apparent utilization method for NFC 
solutions, in the current market state, would be point of sale communication and post 
purchase support. To enable services and communication to the consumers, pre and 
post purchase, thus making the whole purchasing and consumption process more sim-
ple, convenient, and safe as possible.  
Lindqvist et al., state similar benefits in regards to NFC technology; the most apparent 
benefits of the technology are the possibilities for communication via location based 
communication and services, especially with health related information (Lindqvist et al. 
2009). And according to Director A, a solution such as the PIS, could enhance both pre 
and post purchase functions, to the extent that these types of novel solutions could in 
fact be utilized for Health and Medical Marketing purposes. 
 
 
5.2 Consumer Behaviour 
 
 
According to Director A, one key factor would be able to "package" i.e. properly market 
and communicate these types of novel NFC products and services, through the right 
channels, and preferably to the opinion leaders, in order to make these compelling 
enough, so that both the pharmacies and consumers would implement and purchase 
them. Therefore, marketing efforts should be carefully considered and customized to 
meet respective trends, demands and consumer patterns, in order to ultimately con-
vince the remainder of the consumer groups, over the benefits of such NFC solutions. 
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Director A and Director C, respectively, mentioned that in OTC pharmaceuticals, the 
commercial factor is especially important, since these products and services can be 
directly marketed towards the end consumers. Therefore, the key considerations in the 
case of introducing new and novel products or services, such as the PIS, according to 
Director A and Director D, respectively, would be to not make the marketing, advertis-
ing and selling efforts too technology focused and centered. Meaning that, when trying 
to market these types of solutions, emphasis should be placed upon bringing across all 
the benefits gained from these, instead of for example praising or detailing novel tech-
nologies and their functions, and thus running the risk of simply confusing and alienat-
ing the consumers.  
 
In accordance with this, Director B mentioned that many years ago, when the internet 
was emerging, he was asked whether or not he thought that in some year’s time peo-
ple everywhere would use the internet as a daily tool, for both work and leisure. And 
according to him, his response was; “people probably aren’t ready yet”. Therefore, 
according to him, there will always be people who could be against the new technolo-
gies and do not at first see the need for it. However, the main idea is to initially target 
the right set of people, who actually need such solutions as the PIS, people who in fact 
could gain substantial health benefits from the utilization of such solutions. 
Director B also mentioned that, initially the innovative and technologically aware con-
sumer of today, would most likely be willing to use and adopt such novel concepts ra-
ther quickly, if these were indeed marketed and presented correctly, in order to convey 
both the safety and security benefits that these would enable. Whereas, according to 
him, the technologically less capable or aware consumer might be more hesitant to-
wards adopting and using such NFC solutions. 
 
However, according to Director A and Director B, respectively, both mentioned that it is 
a given in today’s society that consumers utilize internet and mobile services and appli-
cations for comparing and obtaining information, and simultaneously receiving com-
munication messages by the influencers, such as the Pharmaceutical companies. 
Therefore, according to Director A, the amount of presence by the companies, in 
online, mobile and point of sale marketing has dramatically increased. And according to 
Director A, especially OTC pharmaceutical marketers have to, and will increasingly uti-
lize electronic and mobile health communication methods, to better reach and service 
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the consumers. And that therefore the utilization of NFC technology solutions in Phar-
maceuticals, according to Director A, can be seen as plausible, due to the possibilities 
for enhancing the means and methods of mobile marketing, sales and services. 
In accordance, Persaud & Azhar state that, mobile devices, with internet access and 
various other capabilities, actually posses the capability to change consumer buying 
experiences, as well as the respective marketing efforts used in the processes. Since 
consumers are nowadays able to instantly search for information, evaluate offerings 
and conduct purchases. 
 
According to Director A and Director C, respectively, the conceivability for NFC technol-
ogy based mobile solutions is much more likely today, than it would have been just a 
few years ago. Since the internet has become one of the most important referees for 
the consumers and that this can also be seen in the behavior of the consumers. Direc-
tor D mentioned that nowadays consumers, even before going to the doctor or phar-
macist, have already conducted personal research and evaluation over products or 
conditions, trough online and mobile mediums or applications.  
And according to all interviewees, respectively, the people of today are more willing 
and inclined towards using electronic and mobile health and medical services.  
According to Director A; today's consumer is more likely to search and compare prod-
uct information, and seek advice through online and mobile mediums, before purchas-
ing for example OTC drugs. Interestingly enough, according to Google, especially 
smart phones have become an indispensable information gathering and buying tool. 
And that these are used throughout the research and decision making process. And 
that information seeking is performed by the majority of smart phone users (Google, 
2010). 
 
In accordance with this, Director D stated that even doctors and other professionals 
usually tend to seek information and advice, through for example online mediums or 
applications, since many medical professionals, much alike consumers, often tend to 
rely more on what other people have stated, as supposed to relying solely on their own 
knowledge. Director A also said that he himself uses his smartphone to access various 
health and medical applications, and according to him, especially mobile communica-
tion means are highly useful and practical, after all most people tend to carry their 
mobile devices with them all the time and everywhere, ergo one is able to access the 
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necessary information at any given time and location. In accordance with these state-
ments are current findings; Statistics Finland states that in 2011, 42 % of the popula-
tion in Finland were in possession of a smartphone. And that 33 % of the population, 
between the ages of 16-74, used the internet on the move (Statistics Finland, 2011). 
 
Director B and Director C, respectively, stressed the point, that the situation with such 
technologies as the NFC - PIS system, is that one would have to convince the techno-
logically aware or innovator groups of the benefits gained from the utilization of these 
solutions, in order to be able to gain any foothold within the markets. And according to 
Director C, if the Pharmaceutical businesses see demand and acceptance from the con-
sumers’ side, they would be more likely to utilize such concepts, and be willing to in-
vest in these. Since, according to Director C, the apparent benefits of such NFC solu-
tions are evident enough to convince at the very least some of the main opinion lead-
ers i.e. doctors and other professionals. 
 
Director A  as well stressed the point, that in order for such types of novel technologies 
to be adopted by both the businesses and consumers alike, firstly one would have to 
convince all parties of the benefits that could be gained from such changes. And sec-
ondly, it is of utmost importance to convince consumers over the ease of use, if indeed 
these systems were to be found user friendly and simple to operate. Similarly, the re-
search on NFC or RFID acceptance has shown that the perceived convenience having 
an significant impact, as well as positive effect on the consumers intention towards 
using the technology (Ohkubo, Suzuki & Kinoshita, 2005 ; Hossain & Prybutok, 2008). 
 
According to Director A, convincing the consumers over the benefits gained, in ex-
change with the added discomfort of learning to operate such NFC solutions, is in fact 
key in regards to the possible adoption of such concepts. Due to the fact that consum-
ers might easily shy away from these solutions if the amount of technical operating 
difficulty would prove too high in comparison to the reaped benefits.  
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5.3 NFC and OTC Pharmaceuticals - the Pharmaceutical Information 
System 
 
 
 
According to Director B;" If this solution could save even one life, then there is enough 
causality and motivation for implementation, from the perspective of the governments 
and businesses" 
 
However, according to Director C and Director D, respectively, currently one barrier for 
this type of system could be the fact that for example the "common man" i.e. techno-
logically less capable or aware consumers would more likely still be inclined to ask the 
pharmacists and doctors for advice. According to Director D, usually the common pref-
erence is to place the responsibility on others, such as the professionals. Therefore the 
barriers for such technologies would become increasingly strong, if for example the 
main recommenders of these solutions would not include also professionals or other 
influencing entities, for example pharmacists, doctors and major drug manufacturers or 
brands. According to Director D, therefore it would be crucial for this type of technolo-
gy be made aware to the consumers, by the professionals or opinion leaders, and with 
the leading example of the bigger and more known drug brands. Similarly, previous 
findings have found that the attitudes of the consumer towards the safety and security 
of NFC or RFID tagged products has been found to directly influence the propensity to 
purchase these products (Boeck et al. 2011). 
 
And according to Director A and Director B, respectively, the consumers are currently 
not the main obstacle, in terms of adoption and acceptance, but that the main obstacle 
lies within the entities that would be willing to invest in such technology, and take the 
risks, with currently no information or research about the perceived acceptance or will-
ingness of consumers to utilize these types of solutions. 
Accordingly, Director A and Director D, respectively, stated that if such NFC solutions 
would indeed be made available, many of the current consumers would definitely uti-
lize these, despite the added technological adaptation or learning that the usage of 
these would require. According to Director A, especially the people who use more than 
one drug simultaneously, and people that have pre-existing allergies, since these con-
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sumers could in fact, in a worst case scenario, be placed in a life threatening situation, 
due to for example unawareness over medication compliance.   
And according to Director A, these consumers who possess the very definite need for 
these types of technologically advanced solutions could possibly simultaneously also 
act as the innovators or early adopters, leading the way towards more wide spread 
consumer acceptance. 
 
Director B brought forward an important consideration, that in the case of OTC phar-
maceuticals, and all pharmaceuticals for that matter, there are two main parameters to 
consider, firstly Safety and secondly Effectiveness. If a new product or service would 
possess or enhance either one of these attributes, that already would constitute as a 
large enough reason for investment, implementation and simultaneously a very com-
pelling sales argument as well. And according to Director B, a solution such the PIS, if 
being fully functional and cross implemented in the products and services, would cer-
tainly possess, and most likely also enhance both parameters. According to Director B, 
therefore the possible infrastructural changes are the main consideration, and barrier 
for current implementation of such NFC solutions, within the respective markets. 
 
Accordingly, Director A and Director B, respectively, stated that many consumers might 
initially view such concepts as not being a necessity, more so if the amount of infra-
structure, i.e. devices and applications, are as scarcely available as is the currently the 
case. Therefore the consumers might not be willing to make acquisitions of for exam-
ple NFC enabled smart phones, simply for the sake of one application.  
And according to Director A, the infrastructural changes is a key concern, according to 
him; if for example the majority of future smartphones would possess the technology 
readily implemented, then the barriers for adoption and usage would be far smaller, 
and most probably these types of NFC based solutions could become widely accepted 
and utilized.  
And according to Director A and Director D, respectively, these systems would fur-
thermore need to preferably be synced with the current and up-coming health and 
medical databases (eArchive), in order to avoid additional infrastructure modifications 
and investments, for the purposes of encompassing all health and medical data of the 
users. 
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Very notable is the mention by Director A, he sees that there is a clear social demand 
for such applications, and that for example the PIS system clearly makes sense, from a 
business perspective, due to the relative advantage that especially these NFC enabled 
products could provide the companies with. In accordance with this, Director B and 
Director D, respectively, mentioned that especially the Pharmaceutical brands should 
have great interest in being the first ones to utilize these types of NFC technology sys-
tems and applications, due the clear competitive advantage these would offer, and the 
ability to stand out positively in comparison to rivaling products or brands that may not 
yet utilize these. Thus, according to Director D, the companies or brands would also be 
establishing themselves as the main brand or company that consumers in their minds 
associate with the novel technology solutions, according to Director D; it’s better to be 
first, than it is to be better. 
 
All interviewees, respectively, stated that one of the key benefits of such a solution as 
the PIS, would the added possibilities for point of sale communication and post pur-
chase services, with added opportunities for more personalized and enhanced service 
and information provision. And according to all interviewees, respectively, the possibili-
ties for post purchase support provide by such NFC systems; can be seen as very im-
portant. Since the consumers would be able to utilize the system to self administer and 
use drugs, even with the simultaneous use of for example prescription medicines, thus 
gaining a substantial benefit, in terms of improving drug compatibility and coherence, 
and possibly even effecting and altering the number of for example ADR cases, for the 
better. 
 
And according to Director A, people with substance or drug allergies would be especial-
ly eager to have such solutions in their possession, since for example certain substanc-
es in everyday OTC drugs, such as painkillers, could be very harmful for some people, 
and in some cases the consumers themselves are not aware of this. Since normally 
people consider that basic drugs like Aspirin or Ibuprofen, are coherently safe, even 
with simultaneous use alongside other drugs.  And according to Director A, this would 
be one scenario where added user safety, as a selling argument, would become appar-
ent. Since one of most apparent added benefits gained from these solutions would be 
the added user safety, and arguably better health. In accordance, Foh (2011) states 
that, mobile health technologies could in fact enable and take over several functions, 
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such as point of sale medical and health guidance, as well as post purchase health and 
medical support (Foh, 2011). 
 
Another point brought forward by Director C, is that these solutions could as well be 
beneficial in terms of financial savings. For example for the pharmacies or even in the 
future the convenience stores, considering if such NFC systems as the PIS, could for 
example lower personnel related costs, due to the system taking over some of the 
main advisory functions. According to Director C, this would mean that even if one 
person’s monthly salary would be sufficient enough to cover the implementation and 
other related costs of these technologies, then the pharmacies would have sufficient 
enough reason to be interested in these solutions. 
 
Interestingly enough, according to the survey conducted by the Association of Finnish 
Pharmacies and PricewaterhouseCoopers, the free professional services offered by the 
pharmacies enable more than 500 million Euros (€) in healthcare savings, annually. Via 
the free health and medical advice and services offered by the pharmacies (Association 
of Finnish Pharmacies 2010). Therefore, the hypothetical economic and financial bene-
fits of such solutions could become very apparent, and could constitute as a significant 
enough reason for considering the utilization of such applications and services, as the 
PIS, from both the Pharmacies and Governments point of view 
 
According to Director A, Director B and Director C, respectively, ultimately the Pharma-
ceutical companies are always after profit, and therefore the willingness to invest in 
both the infrastructural, as well as marketing and advertising changes, would have to 
be backed up by concrete and meaningful advantages. 
 
Director A and Director B, respectively, said that one possible motivator for businesses 
to invest in this type of NFC solution, would be the support or possible exemptions 
provided by the Government. According to Director A, that due to the possible benefits 
reaped from this solution, one could argue that healthcare costs are minimized, since 
people are less likely to suffer from ADRs, and thus less likely to need health or medi-
cal care. Hence the governments as well would be saving money, due to lowered 
healthcare and medical costs of the society at large. 
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And according to Director A, the hypothetically lowered tax rates or other monetary 
exemptions could also enable the products to be sold at competitive prices, with still 
large enough profit ratios for the businesses to be sufficiently interested in investing in 
NFC technology. If in fact these NFC products and services would be sold at aforemen-
tioned competitive prices, this would constitute as a rather strong marketing and sell-
ing point, and would simultaneously lower the barrier for consumer purchase decision 
making as well. According to Director A, when considering the fact that a brand that 
offers this technology in their products, would also be willing or able to sell these at 
reasonable prices, with added benefits in comparison to rivaling products, according to 
him; “this would be a definite win win situation.”  
 
Adding to this, Director B mentioned that the Finnish government could for example be 
willing to lower the TAV tax rates on the products that contain the NFC enabled PIS 
systems, since these could possibly be indirectly linked with benefits, such as improved 
health, and lowered healthcare and medical costs of the society.  
These arguments are very much relevant, when considering estimates by the European 
Union; that the total cost to society of ADRs in the EU is € 79 billion (European Union, 
2008).  
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6 CONCLUSIONS 
 
 
 
The purpose of this thesis was to uncover and assess the possibilities, challenges and 
ultimately the conceivability, of utilizing NFC technology in Health and Medical Market-
ing, specifically within Finnish OTC Pharmaceutical markets.  
For the means of this exploratory research, the PIS concept solution proposed by Jara 
et al. was chosen as the main practical implementation example, in order to more val-
idly assess the aforementioned factors. 
 
The main attempt was to try and shed light upon the question of whether or not NFC 
technology solutions, such as the PIS, would indeed have something meaningful to 
offer, for both the businesses and consumers. 
 
This research can be considered valuable, in terms of portraying the bigger picture of 
Health and Medical marketing, applications and their respective services, in terms of 
their recent developments and assumed future directions, since similar research has 
previously not been conducted within these frameworks. Therefore, the research find-
ings may be used in order to assess factors involved in the utilization of NFC technolo-
gy based applications and services in OTC Pharmaceuticals. And as the interview find-
ings of the research indicated, the possible benefits gained from the utilization of such 
solutions could in fact be rather wide ranging. However, these are accompanied by 
several challenges as well, which as of current may be considered as a rather large 
stepping stone, especially for the Pharmaceutical companies, that presumably would 
be the ones to initially invest and create these solutions. 
 
The following conclusions are divided into three main sections, in accordance with the 
research questions, i.e. possible benefits, challenges and conceivability of utilizing NFC 
technology in OTC Pharmaceutical products and services. 
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6.1 Benefits 
 
 
Drawing from the main interview findings, one may assume that the increase in both 
the supply and demand of Health and Medical applications and services, along with the 
increased usage of both online and mobile services and applications, according to the 
interviewees, can be considered as a positive sign towards both consumer and busi-
ness willingness and readiness towards more enhanced and personalized means of 
Health and Medical marketing. And according to the interviewees, this increases the 
conceivability of the possible introduction of novel NFC technology solutions such as 
the PIS system, into the respective markets. Due to the fact the solution would enable 
the Health and Medical marketers’ to deliver truly meaningful communication and ser-
vices. In other words, promoting and protecting the Health of the consumers. 
 
The growing market of OTC pharmaceuticals, and their increased sales margins, ac-
cording to the interviewees, is one of the main reasons as to why these specific mar-
kets are becoming increasingly interesting and lucrative for the Pharmaceutical compa-
nies. Thus, according to the interviewees, the possible competitive advantage enabled 
by such product and service variations, could be seen as sufficient enough of a causali-
ty, for the both the device and system manufacturers, as well as Pharmaceutical com-
panies, to be interested in creating and implementing these solutions. 
And according to the interviewees, this on the other hand can viewed as an opportuni-
ty for improved marketing and advertising efforts i.e. health and medical based elec-
tronic and mobile communications and services.  
 
Especially in the case of possible future scenarios, where OTC Pharmaceuticals could 
be sold through convenience stores as well. According to the opinions of interviewees, 
in these scenarios one could assume that, since the general exposure and consumer 
base of convenience stores higher than that of for example Pharmacies. And that as-
sumedly the professional advice and support would become lower, in comparison to 
Pharmacies, that in this case both the stores and the Pharmaceutical brands would be 
willing to invest more efforts in various marketing efforts, such as point-of-sale market-
ing, in order to promote and advertise the benefits of such novel products and ser-
vices, i.e. the provision of accurate, accessible and safe information concerning the 
purchase and consumption of Pharmaceuticals. 
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Based upon the opinion of the interviewees, the most apparent benefits for the con-
sumers are rather clear; the NFC technology enabled PIS solution, if fully implemented 
and functional in mobile devices, as well as pharmaceutical products and services – 
could in fact largely enhance the purchase and post purchase processes and consump-
tion of Pharmaceuticals, even to the degree where the Health of the consumers could 
be positively impacted, i.e. the solution could prevent ADR and allergy cases, hence 
preserve the Health of the users. According to the interviewees, this is because in most 
cases the patients themselves may not even be aware of the possible allergic or ad-
verse reactions that may occur with the consumption of prescription-free or OTC 
Pharmaceuticals.  
 
And when considering the possible benefits for the assumed providers of such NFC 
technology solutions, i.e. the Pharmaceutical companies, the interviewees stated as the 
most apparent benefits being the ability to provide a unique service, via the NFC ena-
bled systems and products, and therefore being able to achieve an advantage over the 
competitors. The possible benefits could reach anywhere form; re-structuring Health 
Marketing efforts of the Pharmaceutical companies for the better, with the ability to 
provide much needed accurate and accessible Health and Medical information and ser-
vices to the consumers. And according to the interviewees, this could also positively 
affect sales, since assumedly the purchase and re-purchase rate of the products that 
would contain the added benefit of NFC technology, would most likely be higher that of 
those that do not contain it. 
 
Furthermore, according to the interviewees, there would also be other providers that 
could be very interested in these types of technology solutions, for example the phar-
macies and the government. The interest of the pharmacies could lie within the possi-
ble personnel savings that such solutions could enable, via taking over some of the 
advisory functions. And the government should as well be interested in these solutions; 
since these possess the capability of minimizing medicine consumption related allergy 
and adverse reaction cases, as well as provide major saving in national healthcare ex-
penditures via advisory and guidance function over medicines. Thus, possibly altering 
the amount of overall health related incidents and overall healthcare costs to the socie-
ty, i.e. economic, financial and social benefits. 
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6.2 Challenges 
 
 
The interview findings indicated that there are several challenges, concerning the mo-
mentary conceivability for the creation and implementation of such systems from both 
the business and consumer perspective. A large scale implementation of such solutions 
would require firstly significant infrastructural changes, i.e. majority of mobile device 
manufactures including NFC in their devices. As well as infrastructure changes from the 
information and service supply side, i.e. Pharmaceutical companies, Pharmacies, Na-
tional healthcare and medical systems, as well as from the Governmental side. Second-
ly, the systems would have to coherently safe and secure, with strict rules and regula-
tions, as well as monitoring over implementation and usage, in terms of personal safe-
ty and information security and confidentiality.  
Hence, the current infrastructure levels were identified as being one of the main mo-
mentary barriers. Since NFC technology itself is currently still on the verge of growth, 
and the amount of devices that currently possess the capability to perform these NFC 
based functions, may possibly not be sufficient enough, in order for the main investors 
to take the risk, without sufficient market and consumer experience i.e. actual wants, 
needs and demands from the consumer side.  
 
According to the statements provided by the interviewees, some of the key factors that 
come into play, whilst assessing factors regarding consumers’ acceptance towards NFC 
technology products and services. Firstly the level of technological usage difficulty, 
secondly the security concerns involved with NFC technology use, and thirdly the per-
sonal traits of the individuals in question i.e. personal or community needs towards 
such solutions. Accordingly, the interviewees stated that; one of the main challenges, 
in terms of consumer acceptance and adoption of such NFC solutions, is the ease of 
use in regards to the benefits achieved from the actual system or service usage. In 
other words, the solution should provide the users with significant enough benefits, in 
order for them to be willing to adapt and cope with the usage of such technologies, 
along with their respective devices and services.  
  
Current challenges for mass market implementation and approval became also appar-
ent, whilst examining the interview findings. There are several key considerations that 
need to be taken into account, whilst assessing consumers wants, needs, willingness 
64 
 
and even usage ability towards the technology, especially in the context of Pharmaceu-
tical products and services. Due to the fact that, according to the interviewees, the 
majority of people, when dealing with Pharmaceuticals, even in the case of OTC Phar-
maceuticals, tend to prefer the advice of for example doctors or pharmacists. There-
fore, in order to achieve acceptance and ultimately adoption of these solutions, em-
phasis must be placed upon marketing and promoting these to the opinion leaders. 
According to the interviewees, these initial consumer groups need to firstly, become 
interested, secondly purchase, thirdly be able to actually cope with the use of the 
technology, and lastly to see sufficient enough beneficial gains achieved from the use 
of these products and services, in order for them to positively influence the behaviour 
of the remaining consumer groups.  
Furthermore, according to the interviewees, these assumed innovator or early adopter 
groups would most likely initially consist of consumers with distinct needs towards such 
applications. For example people who use more than one form of medication simulta-
neously, people who have substance allergies or people who are very conscious and 
particular about the safety and general usage of Pharmaceuticals. 
 
 
 
6.3 Conceivability 
 
 
Based upon the opinions of the interviewees, this type of technology solution could be 
more than beneficial for businesses and consumers alike, and thus according to the 
interviewees, it can be considered as possessing immense potential for mobile health 
and medical technologies, as well as their respective methods and means of marketing. 
The possible benefits that were stated by the interviewees, could range anywhere 
from; major savings in national healthcare costs, due to for example taking over some 
of the advisory and guidance functions and hypothetically reducing the amount of ADR 
incidents. Or improved profit ratios, due to for example governmental tax exemptions. 
Also, according to the interviewees, one may assume that these could be accompanied 
by the increased sales of the products and services that contain the technology, due to 
their specialized and unique offering. And last but, very certainly not least, the inter-
viewees were in the opinion that the assumable benefits for the consumers, the actual 
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users of these solutions, would be very considerable – with enhanced purchase and 
post purchase communication and support, concerning the consumption and usage of 
medicinal products, accessible through the users own mobile devices, at any given 
time and place, i.e. numerous Health and Medical related benefits for the users. 
 
According to the interviewees, there is a clear role that such NFC technology solutions 
could play in the future of Health and Medical marketing efforts. After all the purpose 
of Health Marketing is to create, communicate and deliver Health information and ser-
vices, in order to promote and protect the Health of the consumers. According to the 
interviewees, in essence, the PIS would be meant for these exact purposes – therefore 
there is not only a clear plausibility for the utilization of such solutions, according to the 
interviewees; there is a clear need for such solutions, since assumedly these solutions 
could improve and make the purchase and consumption processes of medications 
more accurate and safe i.e. providing overall Health benefits to the consumers.  
 
Concluding the opinions of the interviewees concerning the current conceivability of 
the assessed scenario, the assumption can be made that, at the very least the Phar-
maceutical manufacturers or marketers should have sufficient causality to look into 
these types of solutions, whether form an economic, social or financial stand point - 
despite the amount of overall changes and investments that this scenario would re-
quire. However, one key take away from the interview findings is that; if in fact such 
solutions would be made into reality, and available for consumer use and purchase, the 
hypothetical timeframe of this happening, may most likely be still years away. 
 
 
 
6.4 Limitations and Future Research 
 
 
There were limitations to this research. The lack of existing concept solutions, such as 
the PIS solution, did not allow to field test these applications. In order to validly assess 
and determine factors concerning the usage and resulting implications, one would have 
had to firstly, create the solution, with the help of experienced professionals.  And sec-
ondly, one would have had to gain access to national healthcare databases of the test 
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subjects, and preferably with the allowance and co-operation of Pharmacies, in order 
to conduct realistic field testing within the examined sales outlets. 
Simultaneously, the same limitations apply to the assessment over consumer behav-
iour, in regards to the actual acceptance and usage of the proposed system solution. 
As the research relied on the findings from existing literature and qualitative interview 
materials, and due to the lack of existing research concerning the topic and proposed 
scenario of the research, the findings can be considered as exploratory.  
 
Nevertheless, validity for the research questions was achieved, since the core aim was 
to determine the possible benefits, challenges and ultimately conceivability of utilizing 
NFC technology in Health and Medical marketing, more specifically in OTC Pharmaceu-
tical products and services. 
 
Therefore it would be of even greater use, for both the Pharmaceutical businesses, as 
well as for the consumers at large, if future work would dive deeper into the actual 
functionality and usage aspects of such concept solutions and their respective users.  
 
The apparent need to firstly create and secondly more extensively test such concept 
solutions is evident. In order to more explicitly determine the benefits and challenges 
that may arise with mass market trial and usage. Consequently finding definite an-
swers to the question of; whether in fact such technology solutions actually possess 
the capability of becoming the next big breakthrough in Health and Medical marketing. 
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